| scholarly article | Q13442814 |
| P50 | author | Peter S. Jensen | Q37383431 |
| P2093 | author name string | Nina R Schooler | |
| Joseph C Blader | |||
| Vivian Kafantaris | |||
| Steven R Pliszka | |||
| P2860 | cites work | Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder | Q28189803 |
| Treatment of attention-deficit/hyperactivity disorder: overview of the evidence | Q28254103 | ||
| Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation | Q28331086 | ||
| Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design | Q33180244 | ||
| Stimulant medications | Q33608974 | ||
| Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings | Q33949664 | ||
| Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. | Q33960193 | ||
| Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. | Q34131298 | ||
| The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder | Q34529904 | ||
| Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. | Q34556434 | ||
| Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents | Q34613195 | ||
| Defining clinical phenotypes of juvenile mania | Q35075420 | ||
| Second-generation antipsychotic medications in children and adolescents | Q36009445 | ||
| Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda. | Q36535987 | ||
| Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. | Q36741979 | ||
| Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder. | Q39935367 | ||
| Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment | Q44949269 | ||
| Stimulant dosing for children with ADHD: a medical claims analysis | Q46121326 | ||
| Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study | Q46365535 | ||
| Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. | Q50960243 | ||
| National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. | Q51801492 | ||
| Improving mental health services in primary care: reducing administrative and financial barriers to access and collaboration. | Q51870892 | ||
| Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. | Q52295720 | ||
| Trends in the Use of Typical and Atypical Antipsychotics in Children and Adolescents | Q58822795 | ||
| A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD | Q73256558 | ||
| Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder | Q73944411 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e796-806 | |
| P577 | publication date | 2010-09-13 | |
| P1433 | published in | Pediatrics | Q7159238 |
| P1476 | title | Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD | |
| P478 | volume | 126 |
| Q37653402 | A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. |
| Q36610730 | A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation |
| Q37988784 | ADHD and delinquency--a developmental perspective |
| Q22241474 | ADHD: an integration with pediatric traumatic brain injury |
| Q34167783 | Aggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury |
| Q92201819 | Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder |
| Q35931799 | Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder |
| Q49212922 | Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study |
| Q28069569 | Disruptive mood dysregulation disorder: current insights |
| Q41689257 | Do Omega-3/6 Fatty Acids Have a Therapeutic Role in Children and Young People with ADHD? |
| Q41863434 | Effect of methylphenidate and folic Acid on ADHD symptoms and quality of life and aggression: a randomized double blind placebo controlled clinical trial |
| Q36654483 | Impulsive Aggression as a Comorbidity of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents |
| Q59813705 | In vitro pharmacological characterization of SPN-810M (molindone) |
| Q92896225 | Maladaptive Aggression: With a Focus on Impulsive Aggression in Children and Adolescents |
| Q56095088 | Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies |
| Q28295134 | Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications |
| Q38559026 | Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder |
| Q38839950 | Pharmacotherapy of conduct disorder: Challenges, options and future directions. |
| Q47586182 | Practitioner Review: Definition, recognition, and treatment challenges of irritability in young people. |
| Q36708005 | Prevalence and Treatment Outcomes of Persistent Negative Mood Among Children with Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior |
| Q34063651 | Psychotropic medication characteristics for special education students with emotional and/or behavioral disorders |
| Q38066274 | Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review |
| Q55040791 | Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study. |
| Q88042880 | Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults |
| Q36707994 | The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School |
| Q35595839 | The treatment of severe child aggression (TOSCA) study: Design challenges |
| Q27002372 | Using stimulants to treat ADHD-related emotional lability |
Search more.